Search Diabetes In Control

Previous | All Articles This Week | Next

This article originally posted 07 June, 2011 and appeared in Medication, GLP-1 Series Issue 1, GLP-1 Agonist

The Incretin Effect

For the complete article, The Incretin Effect, and information on other aspects of GLP-1 treatment, please visit Novo Nordisk's diabetesinamerica at www.novomedlink.com/diabetes/diabetes-in-america.

A Nurse's Perspective: Martha M. Funnell, MS, RN, CDE Lixisenatide Once-Daily GLP-1 Drug Effective for Type 2 Diabetes SPECIAL GLP-1 TEST YOUR KNOWLEDGE ANSWER, PART 5

An African-American Man with Type 2 Diabetes and Obesity

GLP-1 Editor's Note:

| Print | Category | Home

This article originally posted 07 June, 2011 and appeared in Medication, GLP-1 Series Issue 1, GLP-1 Agonist

Diabetes In Control Advertisers

Cast Your Vote

Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

View All Polls »

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control

Privacy / Advertising With Us / Contact Us

Entries (RSS News)

Add us to your favorite news reader

DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.

The Incretin Effect

Related Articles